SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the mean SKP2 protein levels were significantly higher in the CML patients compared to the control subjects (4.4 ± 1.5 vs. 1.2 ± 0.6, (p < 0.001) (Table 1, Figure 2).